Oxaliplatin, 5FU and nab-paclitaxel as neoadjuvant regimen in patients with resectable oesogastric adenocarcinoma: A GERCOR phase 2 study (FOXAGAST).

Affiliation auteurs!!!! Error affiliation !!!!
TitreOxaliplatin, 5FU and nab-paclitaxel as neoadjuvant regimen in patients with resectable oesogastric adenocarcinoma: A GERCOR phase 2 study (FOXAGAST).
Type de publicationJournal Article
Year of Publication2018
AuteursWatson SSophie, de la Fouchardiere C, Kim SChong Hun, Cohen R, Bachet J-B, Tournigand C, Ferraz J-M, Lefevre M, Colin D, Svrcek M, Meurisse A, Louvet C
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume36
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2018.36.15_suppl.4035